Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Revenue: 2016-2025

Historic Revenue for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $161.7 million.

  • Tg Therapeutics' Revenue rose 92.79% to $161.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $531.9 million, marking a year-over-year increase of 100.88%. This contributed to the annual value of $329.0 million for FY2024, which is 40.80% up from last year.
  • Latest data reveals that Tg Therapeutics reported Revenue of $161.7 million as of Q3 2025, which was up 14.57% from $141.1 million recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Revenue ranged from a high of $165.8 million in Q3 2023 and a low of $80,000 during Q4 2022.
  • Moreover, its 3-year median value for Revenue was $83.9 million (2024), whereas its average is $89.7 million.
  • Per our database at Business Quant, Tg Therapeutics' Revenue tumbled by 96.55% in 2022 and then skyrocketed by 176,298.94% in 2023.
  • Over the past 5 years, Tg Therapeutics' Revenue (Quarterly) stood at $2.3 million in 2021, then slumped by 96.55% to $80,000 in 2022, then surged by 54,863.75% to $44.0 million in 2023, then surged by 146.04% to $108.2 million in 2024, then skyrocketed by 92.79% to $161.7 million in 2025.
  • Its Revenue stands at $161.7 million for Q3 2025, versus $141.1 million for Q2 2025 and $120.9 million for Q1 2025.